← Back to Search

Other

Intranasal capsaicin for Non-Allergic Rhinitis

Phase 3
Recruiting
Led By Kunal R Shetty, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks post treatment, 12 weeks post treatment
Awards & highlights

Study Summary

This trial studied how people with non-allergic rhinitis respond to capsaicin treatment and if IgE levels change.

Eligible Conditions
  • Non-Allergic Rhinitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks post treatment, 12 weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks post treatment, 12 weeks post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in maximum optical density determined via optical rhinometry
Change in nasal itching as measured by the visual analog scale (VAS)
Change in nasal obstruction as measured by the visual analog scale (VAS)
+2 more
Secondary outcome measures
Change in local IgE level

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

American Academy of Otolaryngic Allergy & FoundationUNKNOWN
1 Previous Clinical Trials
36 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
914 Previous Clinical Trials
324,339 Total Patients Enrolled
Kunal R Shetty, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~6 spots leftby Jun 2025